Abiopharma

News list

Woods-Keisling Sharon 🔴 sold 10.0K shares (1 derivative) of Spok Holdings, Inc (SPOK) at $11.00 Transaction Date: May 05, 2026 | Filing ID: 000004

Full text

News bot May 6, 2026, 8:31 p.m.
🔍 Woods-Keisling Sharon (Executive)

Company: Spok Holdings, Inc (SPOK)

Report Date: 2026-05-05
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares sold: 10,000
Detailed Transactions and Holdings:
- Sold 10,000 shares of Common Stock at $11.0036 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 26,036.00 | transaction_form_type: 4
- Sold 0 shares of Restricted Stock Unit (Derivative)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 48,264.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
Footnotes:
- F1: Each Restricted Stock Units ("RSUs") represents a contingent right to receive one share of the issuer's Common Stock.